PHARMACY

Merck wins patent infringement suits against Mylan

BY Alaric DeArment

WHITEHOUSE STATION, N.J. — Mylan will be barred from marketing a generic version of a Merck cardiovascular drug until the drug’s patent expires, under a court ruling announced Friday.

Merck said the U.S. District Court for the District of New Jersey ruled against Mylan in two patent infringement suits related to the drugs Zetia (ezetimibe) and Vytorin (ezetimibe and simvastatin). Specifically, the court ruled that a patent covering the drug, RE 42,461, is valid and enforceable and enjoined Mylan from launching until the patents expiration in April 2017.

Mylan had been seeking Food and Drug Administration approval for generic versions of Zetia and Vytorin, prompting Merck to file suit against it in December 2009 for Vytorin, and in June 2010 for Zetia.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?

View Results

Loading ... Loading ...
PHARMACY

Mylan to launch generic version of Nuvigil in 2016

BY Alaric DeArment

PITTSBURGH — Mylan plans to start selling a generic version of a drug for sleep disorders starting in June 2016, under a deal with Teva announced Monday.

Mylan said it had settled with Teva over the former’s generic version of Nuvigil (armodafinil) tablets, a drug used to treat sleepiness related to sleep apnea, narcolepsy and shift work disorder.

Mylan plans to sell the generic in the 50-mg, 150-mg and 250-mg strengths. Under the opinion that it was the first company to successfully file for Food and Drug Administration approval of the drug, Mylan said it expects to receive 180 days of market exclusivity in which to directly compete with Teva’s product.

Nuvigil had sales of $296 million in 2011, according to IMS Health. Teva has owned rights to the drug since it finalized its acquisition of Cephalon in October 2011.


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?

View Results

Loading ... Loading ...
PHARMACY

Whooping cough vaccine now available at Walgreens, Take Care Clinics in Arizona

BY Allison Cerra

DEERFIELD, Ill. — Walgreens announced that it is offering Arizona residents protection against whooping cough, also known as pertussis, at all of the drug store chain’s points of care throughout the state.

Walgreens said immunizations (tetanus/diphtheria/pertussis-Tdap vaccine) now are available at more than 275 Walgreens pharmacies and Take Care Clinics throughout Arizona. Walgreens pharmacists in Arizona can administer the whooping cough vaccine to patients ages 7 to 17 years with a prescription, as well as to those ages 18 years and older without a prescription. Take Care Clinics, located at 28 Walgreens in Maricopa and Pima counties, can administer the vaccine to those older than age 10 years.

The announcement follows information from the Maricopa County department of public health, which reported a 41% increase in its number of whooping cough cases in 2011 over the previous year and more than double the number of cases reported in 2009. Latest pertussis immunization recommendations for children and adults, as well as vaccine information, visit the Arizona Department of Health Services website at Azdhs.gov.

"We share in the recommendations of health officials that one of the best things people can do to keep themselves and their families healthy during a possible outbreak is to get vaccinated," Arizona market pharmacy director for Walgreens Laura Zimmerly said. "In addition to children, who are the most vulnerable, those who care for or are in contact with children should also be immunized. We hope that through greater access to immunizations, we can keep our communities healthy and help limit the spread of the virus."


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

telling it like it is says:
Apr-28-2012 09:26 am

God I hope we don't have to call these people at home to drum up business in this area or deal with having to give a minimum number of these shots per week.

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?

View Results

Loading ... Loading ...